Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Hopeforthebeston Aug 26, 2023 4:44pm
130 Views
Post# 35606884

RE:RE:Meaning of it.

RE:RE:Meaning of it.it is evident from yesterday's futile attempt by gagnon to deflect and further delay from the upcoming 2nd qrtr results that they will not be pretty. Is this the best this incompetent businessman and scientist has? The extension of the contract to Symrise is further testemant that the group of people running this company and has sentenced Ceapro to prolonged purgatory. Ceapro will remain a 1 skew product company selling to 1 customer now till 2026. Q2 results (when they finally come) will only further prove that under gagnon's leadership that expenses will continue to increase while profits dwindle driving the stock rice to new lows. 
But do not forget the pipeline as we have been told time and time again, look at the pipeline and the potential it provides to Ceapro. Unfortunately with gagnon at the helm (who has shown numeruous times he is 1- a lier, 2- not a businessman, 3 - incappable of running a human trial and 4 - breaks all proevious deadlines) to no show Ronnie and how about our revenue officier who since her hire has not provide 1 qrtr of growth, new customers etc. 
Scewed blue and tattooed we are.

<< Previous
Bullboard Posts
Next >>